Singapore markets close in 4 hours 14 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
20.700+0.250 (+1.22%)
As of 11:59AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 52.13B
Enterprise value 42.00B
Trailing P/E 7.58
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)0.88
Enterprise value/revenue 0.56
Enterprise value/EBITDA 6.48

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-23.69%
S&P500 52-week change 322.64%
52-week high 327.700
52-week low 318.480
50-day moving average 320.156
200-day moving average 321.103

Share statistics

Avg vol (3-month) 3746.81k
Avg vol (10-day) 3881.35k
Shares outstanding 5219.9M
Implied shares outstanding 62.55B
Float 8875.39M
% held by insiders 10.00%
% held by institutions 129.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.81
Forward annual dividend yield 43.97%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 33.66%
5-year average dividend yield 43.07
Payout ratio 430.14%
Dividend date 3N/A
Ex-dividend date 414 Jun 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 5.37%
Operating margin (ttm)1.89%

Management effectiveness

Return on assets (ttm)3.71%
Return on equity (ttm)12.11%

Income statement

Revenue (ttm)75.52B
Revenue per share (ttm)46.45
Quarterly revenue growth (yoy)8.40%
Gross profit (ttm)N/A
EBITDA 5.16B
Net income avi to common (ttm)4.06B
Diluted EPS (ttm)2.700
Quarterly earnings growth (yoy)-46.30%

Balance sheet

Total cash (mrq)22.04B
Total cash per share (mrq)13.56
Total debt (mrq)11.95B
Total debt/equity (mrq)32.58%
Current ratio (mrq)1.54
Book value per share (mrq)21.48

Cash flow statement

Operating cash flow (ttm)4.1B
Levered free cash flow (ttm)1.02B